Scope Biosciences

Scope Biosciences develops the scope Dx platform, a CRISPR-Cas powered molecular diagnostic tool designed for on-site pathogen testing in the agricultural sector. The technology provides PCR-level sensitivity and single nucleotide specificity to detect crop diseases pre-symptomatically in under an hour. The company targets growers and agricultural operations seeking to enhance crop yields and secure food systems through early intervention and field-based monitoring.